Invivyd, Inc. (IVVD)
NASDAQ: IVVD · IEX Real-Time Price · USD
1.150
-0.070 (-5.74%)
At close: Jul 19, 2024, 12:00 AM
1.140
-0.010 (-0.87%)
Pre-market: Jul 22, 2024, 9:13 AM EDT
Invivyd Employees
As of December 31, 2023, Invivyd had 95 total employees, including 94 full-time and 1 part-time employees. The number of employees increased by 9 or 10.47% compared to the previous year.
Employees
95
Change (1Y)
9
Growth (1Y)
10.47%
Revenue / Employee
n/a
Profits / Employee
-$2,177,032
Market Cap
137.21M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 95 | 9 | 10.47% |
| Dec 31, 2022 | 86 | -17 | -16.50% |
| Dec 31, 2021 | 103 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Amylyx Pharmaceuticals | 384 |
| Cellectis | 221 |
| Electromed | 170 |
| Inventiva | 123 |
| EUDA Health Holdings | 106 |
| Vigil Neuroscience | 69 |
| Corvus Pharmaceuticals | 28 |
| DiaMedica Therapeutics | 19 |
IVVD News
- 21 days ago - Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 5 weeks ago - Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants - GlobeNewsWire
- 6 weeks ago - Invivyd to Participate at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial - GlobeNewsWire
- 7 weeks ago - Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer - GlobeNewsWire
- 7 weeks ago - Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC) - GlobeNewsWire
- 2 months ago - Invivyd Elects Two New Independent Members to its Board of Directors - GlobeNewsWire
- 2 months ago - Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference - GlobeNewsWire